You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rare cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

European Reference Network on Rare Adult Solid Cancers

Recruiting
  • Head and Neck Cancer
  • +4 more
  • observation
  • Brno, Czechia
  • +10 more
Aug 1, 2022

Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

Recruiting
  • Non Small Cell Lung Cancer
  • immunity therapy
  • Changsha, Hunan, China
  • +1 more
Feb 28, 2022

Rare Subtypes of Gastrointestinal Cancers

Recruiting
  • Cancer of Gastrointestinal Tract
    • Aarhus N, Denmark
      Department of Oncology, Aarhus University Hospital
    Feb 14, 2022

    Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

    Recruiting
    • Nasopharyngeal Cancer
    • Epstein-Barr Virus Related Carcinoma
    • FDG-PET
    • Galium-68 DOTATATE
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    Skin Squamous Cell Carcinoma, Appendix Adenocarcinoma, Rare Lesion Trial in Houston (Atezolizumab, Cobimetinib)

    Active, not recruiting
    • Skin Squamous Cell Carcinoma
    • +11 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 3, 2022

    Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

    Recruiting
    • Genitourinary Cancer
    • +7 more
    • La Jolla, California
    • +5 more
    Jul 5, 2022

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022

      Gynecologic Cancer, Skin Cancer, Head Neck Cancer Trial in Worldwide (Stereotactic body radiotherapy, Palliative RT)

      Recruiting
      • Gynecologic Cancer
      • +14 more
      • Stereotactic body radiotherapy
      • Palliative RT
      • Gent, Belgium
      • +6 more
      May 9, 2022

      Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

      Active, not recruiting
      • Rare Histiocytic Disorders (RHDs)
      • +7 more
      • Registry study
      • Los Angeles, California
      • +13 more
      Dec 13, 2022

      Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

      Recruiting
      • Soft Tissue Sarcoma
      • +9 more
      • Patient with Soft Tissue Sarcoma
      • Besancon, France
      • +13 more
      Oct 11, 2022

      Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

      Recruiting
      • Solid Tumor
      • +11 more
      • Belfast, United Kingdom
      • +16 more
      Mar 2, 2023

      Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

      Recruiting
      • Solid Tumor
      • Haematological Malignancy
      • Belfast, United Kingdom
      • +24 more
      Jan 31, 2023

      Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

      Recruiting
      • Cancer of Unknown Primary Site
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 31, 2022

      Extranodal Lymphoma or Lymphoma of Rare Pathological Types

      Not yet recruiting
      • Lymphoma
      • +8 more
      • No interventions need to be specified for this study
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Jun 15, 2023

      Advanced Rare Tumours Trial in Canada (Durvalumab, Tremelimumab)

      Active, not recruiting
      • Advanced Rare Tumours
      • Edmonton, Alberta, Canada
      • +12 more
      Jan 25, 2022

      Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

      Not yet recruiting
      • Schwannomatosis
      • +2 more
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Jan 5, 2023

      Tumor Biopsy in Creating Research Tissue Registry in

      Recruiting
      • Inflammatory Breast Carcinoma
      • +2 more
      • Biospecimen Collection
      • +3 more
      • Houston, Texas
      • +4 more
      Jan 6, 2023

      Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

      Active, not recruiting
      • Advanced Rare Tumours
      • Calgary, Alberta, Canada
      • +16 more
      Mar 17, 2022

      Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Malignancy, Malignant Tumor, Lymphoproliferative Disorders Trial in United Kingdom (Atezolizumab)

      Not yet recruiting
      • Malignancy
      • +8 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Personalized Sequence for Thoracic, Esophageal, and H&N Cancer

      Recruiting
      • Lung Cancer
      • Genetic test
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Mar 18, 2021

      Ewing's Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in New York, Dallas (pbi-shRNA™ EWS/FLI1 Type 1 LPX)

      Active, not recruiting
      • Ewing's Sarcoma
      • +6 more
      • pbi-shRNA™ EWS/FLI1 Type 1 LPX
      • New York, New York
      • +1 more
      Mar 14, 2022

      Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 28, 2023

      Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

      Recruiting
      • Locally Advanced Undifferentiated Pleomorphic Sarcoma
      • +3 more
      • Sintilimab
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 31, 2022